CrushSCI.com
177.2平均天数
186中位天数
30最短天数
373最长天数
672025发文量

Paper Review Records

全部论文审稿周期

15 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

239 天

Comparative Effectiveness of Sacubitril/Valsartan Versus Sodium-Glucose Cotransporter 2 Inhibitors among Patients with Heart Failure with Reduced Ejection Fraction with or without Diabetes: A Cohort Study

作者
Munaza Riaz; Steven M. Smith; David E. Winchester; Eric A. Dietrich; Haesuk Park展开收起
作者单位
1. Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, USA; 2. Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, USA; 3. Division of Cardiovascular Medicine, Department of Medicine, College of Medicine, University of Florida, Gainesville, USA; 4. Department of Pharmacy Education and Practice, College of Pharmacy, University of Florida, Gainesville, USA展开收起
PDF源文件 DOI 网页
68 天

When Methods Matter: An Umbrella Review of Lorundrostat and the Impact of Analytical Decisions on Reported Blood Pressure and Safety Outcomes

作者
Zeyad Elariny; Omar Salem; Mohamad Ashraf Salaheldin; Adham Ahmed; Farida Rabie; Maryam Mohamed Sayed; Mohamed Harish; Mohamed Ali; Selim Ahmed Eliwa; Mohammad Elshorbagy; Sara ElHarouni; Ahmed Abdelmeguid; Retaj Ahmed; Omnia Azmy Nabeh展开收起
作者单位
1. Kasr Al-Ainy Faculty of Medicine, Cairo University, Cairo, Egypt; 2. Faculty of Medicine, Benha National University, Obour City, Egypt; 3. Lecturer of Pharmacology, Kasr Al-Ainy Faculty of Medicine, Cairo University, Cairo, Egypt展开收起
PDF源文件 DOI 网页
126 天

Aspirin Versus Clopidogrel as Single Antiplatelet Therapy After TAVI: A Propensity Score-Matched, Retrospective Analysis

作者
Anastasios Apostolos; Konstantinos Konstantinou; Mohammed Allaf; Athanasios Sakalidis; Konstantinos Kalogeras; Ee Ling Heng; Simon Davies; Alison Duncan; Miles Dalby; Saeed Mirsadraee; Tarun Mittal; Aigul Baltabaeva; Tito Kabir; Mohammed Majid Akhtar; Robert Smith; Vasileios Panoulas展开收起
作者单位
1. Royal Brompton and Harefield Hospitals, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK; 2. Faculty of Medicine, Imperial College London, London, UK; 3. National Heart and Lung Institute, Imperial College London, London, UK展开收起
PDF源文件 DOI 网页
257 天

Empagliflozin in STEMI Patients: A Randomized Controlled Trial on Left Ventricular Recovery and Cardiovascular Outcomes

作者
Fatemeh Baharvand; Roxana Mehran; Francesca Maria Di Muro; Alieh Mohammadi; Mohammadreza Aghajankhah; Shiva Parvaneh; Niloufar Akbari Parsa; Soheil Hassanipour; Ehsan Aboutaleb; Yaser Jenab; Somayeh Bashiri Aliabadi展开收起
作者单位
1. Department of Cardiology, Healthy Heart Research Center, Heshmat Hospital, School of medicine, Guilan University of Medical Sciences, Rasht, Iran; 2. The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, USA; 3. Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran; 4. Department of Pharmaceutics, School of pharmacy, Guilan University of Medical Sciences, Rasht, Iran; 5. Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran展开收起
PDF源文件 DOI 网页
105 天

Food Effects on the Pharmacokinetics of Single Dose and Steady-State Ralinepag, a Novel Oral Prostacyclin Agonist, in Healthy Volunteers

作者
Daniel Lachant; Cristian E. Botta; George Giannakoulas; Natalie Patzlaff; Scott Seaman; Meredith Broderick; Maria Guido; Søren Mellemkjær; Zeenat Safdar展开收起
作者单位
1. University of Rochester Medical Center, Rochester, USA; 2. Department of Heart Failure and Pulmonary Arterial Hypertension, Sanatorio Privado San Gerónimo, Santa Fe, Argentina; 3. Aristotle University of Thessaloniki, Thessaloniki, Greece; 4. United Therapeutics Corp, Durham, USA; 5. UC Health, Cincinnati, USA; 6. Aarhus University Hospital, Aarhus, Denmark; 7. Houston Methodist Lung Center, Houston, USA; 8. HMRI, Houston, USA; 9. Weill Cornell College of Medicine, New York, USA; 10. Texas A&M College of Medicine, Bryan, USA展开收起
PDF源文件 DOI 网页
373 天

Using Artificial Intelligence to Identify Patterns and Predictors of Adverse Drug Reactions in Cardiovascular Patients: A Comprehensive Narrative Review

作者
Erfan Shahabinejad; Fatemeh Soflaei-Shahrbabak; Marzieh Gholami Shoa; Aida Azhdarimoghaddam; Mehrdad Mozafar; Pouya Yektaee-Rad; Samar Monajemi; Shayan Ghanouni; Shuhao Qiu; Mani Khorsand Askari展开收起
作者单位
1. Student Research Committee, Rafsanjan University of Medical Sciences, Rafsanjan, Iran; 2. USERN Office, Rafsanjan University of Medical Sciences, Rafsanjan, Iran; 3. Faculty of Pharmacy, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran; 4. Student Research Committee, Zahedan University of Medical Sciences, Zahedan, Iran; 5. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran; 6. Faculty of Medicine, Guilan University of Medical Sciences, Rasht, Iran; 7. Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran; 8. Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran; 9. Department of Medicine, University of Toledo, Toledo, USA展开收起
PDF源文件 DOI 网页

FAQ

American Journal of Cardiovascular Drugs审稿要多久?

截至2026-11-18,CrushSCI 收录了 American Journal of Cardiovascular Drugs 的 15 篇完整审稿记录。最快一篇从收稿到录用用了 30 天(Author’s Reply to: “Comment on: Colchicine for the Secondary Prevention of Cardiovascular Diseases: A Cumulative-Dose Meta-analysis of Randomized Controlled Trials Including 31,397 Subjects Worldwide”,2026-03-31 收稿,2026-04-30 录用),最慢一篇用了 373 天;平均 177.2 天,中位数 186 天。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。